Dialysis services leader Nephrocare Health Services, operating under NephroPlus, has received Sebi’s approval to launch its IPO, comprising a ₹353.4 crore fresh issue and 1.27 crore shares OFS. Proceeds will fund new dialysis centres, debt repayment, and corporate needs.